KB ISOFLURANE

البلد: أستراليا

اللغة: الإنجليزية

المصدر: APVMA (Australian Pesticides and Veterinary Medicines Authority)

العنصر النشط:

ISOFLURANE

متاح من:

KNIGHT BENEDIKT AUSTRALIA PTY LTD

الشكل الصيدلاني:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

تركيب:

ISOFLURANE ANAESTHETIC Active 100.0 %

الوحدات في الحزمة:

100 mL; 250 mL

الفئة:

VM - Veterinary Medicine

المجال العلاجي:

ANAESTHETICS/ANALGESICS

ملخص المنتج:

Poison schedule: 4; Withholding period: ; Host/pest details: BIRDS - ORNAMENTAL: [ANAESTHETIC - SURGERY, INHALATION ANAESTHETIC]; CAT: [ANAESTHETIC - SURGERY, INHALATION ANAESTHETIC]; DOG: [ANAESTHETIC - SURGERY, INHALATION ANAESTHETIC]; HORSE: [ANAESTHETIC - SURGERY, INHALATION ANAESTHETIC]; REPTILE: [ANAESTHETIC - SURGERY, INHALATION ANAESTHETIC]; SMALL MAMMALS: [ANAESTHETIC - SURGERY, INHALATION ANAESTHETIC]

الوضع إذن:

Registered

تاريخ الترخيص:

2022-07-01

نشرة المعلومات

KB ISOFLURANE
89687 / 125803
Product Name:
APVMA Approval No:
Label Name:
KB ISOFLURANE
Signal Headings:
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
READ SAFETY DIRECTIONS BEFORE OPENING OR USING
Constituent
Statements:
100% Isoflurane
Claims:
For use only by a registered veterinarian.
A potent non-irritant, inhalation anaesthetic, used for induction and
maintenance of general
anaesthesia for all types of veterinary surgery in horses, cats, dogs,
ornamental birds,
reptiles and small mammals.
Net Contents:
100 mL, 250 mL
Directions for Use:
Restraints:
NOT TO BE USED in animals intended to be used or processed for human
consumption.
DO NOT USE on horses that may be used for human consumption.
Contraindications:
KB ISOFLURANE is contraindicated in animals with known sensitivity to
isoflurane or other
halogenated agents or with a known susceptibility to malignant
hyperthermia.
Precautions:
Use with caution when using isoflurane to anaesthetise an animal with
a head injury,
consideration should be given as to whether artificial ventilation is
appropriate to maintain
normal CO2 levels, so that cerebral blood flow does not increase.
In man, the action of muscle relaxants, especially those of the
non-depolarising type such
as atracurium, pancuronium or vecuronium is enhanced by isoflurane.
Similar potentiation RLP APPROVED
might be expected to occur in the target species, although there is
little direct evidence to
this effect.
The concurrent use of sedative or analgesic drugs is likely to reduce
the level of isoflurane
required to induce and maintain anaesthesia. For example, opiates,
alpha-2-agonists,
acepromazine and benzodiazepines have been reported to reduce the MAC
values.
Particular caution should be exercised if administering a
midazolam-ketamine combination
to an animal already anaesthetised with isoflurane.
Isoflurane has been reported to interact with dry carbon dioxide
absorbents to form
carbon monoxide. In order to minimise the risk of formation of carbon
monoxide in